Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2015

01.01.2015 | 2014 SSAT Plenary Presentation

Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection

verfasst von: Thomas Curran, Barbara A. Pockaj, Richard J. Gray, Thorvardur R. Halfdanarson, Nabil Wasif

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Conflicting data exist on predictors of nodal metastases and their impact on survival in patients with pancreatic neuroendocrine tumors (PNETs). We aim to identify factors associated with lymph node involvement and evaluate the effect of nodal metastases on survival.

Methods

All patients undergoing surgery for PNETs in the Surveillance, Epidemiology, and End Results (SEER) tumor registry from 1988 to 2010 were included. Predictors of lymph node involvement and disease-specific survival (DSS) were evaluated using logistic regression and Cox regression, respectively.

Results

Patients (1,915) underwent surgery for a PNET (62 % nonfunctional). Nodal positivity was associated with increasing tumor size (p < 0.001) and grade (p < 0.001). Unadjusted DSS at 5 years was 81 % for N0, 74 % for Nx, and 69 % for N1, respectively, (p < 0.001). After adjustment for tumor size and grade, DSS was significantly decreased in N1 patients (HR 1.57; 95 % CI 1.23–1.95). For patients who had at least one node examined and had low-grade PNETs <1 cm, no nodal metastases were found.

Conclusions

High tumor grade and increasing size predict nodal metastases in patients with PNETs. N1 status is independently associated with decreased DSS. Low-grade tumors <1 cm may be observed or enucleated.
Literatur
1.
Zurück zum Zitat Yao, J.C., M. Hassan, A. Phan, C. Dagohoy, C. Leary, J.E. Mares, E.K. Abdalla, J.B. Fleming, J.N. Vauthey, A. Rashid and D.B. Evans, One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol, 2008. 26(18): p. 3063–72.PubMedCrossRef Yao, J.C., M. Hassan, A. Phan, C. Dagohoy, C. Leary, J.E. Mares, E.K. Abdalla, J.B. Fleming, J.N. Vauthey, A. Rashid and D.B. Evans, One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol, 2008. 26(18): p. 3063–72.PubMedCrossRef
2.
Zurück zum Zitat de Herder, W.W., Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab, 2007. 21(1): p. 33–41.PubMedCrossRef de Herder, W.W., Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab, 2007. 21(1): p. 33–41.PubMedCrossRef
3.
Zurück zum Zitat Modlin, I.M., K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, R.V. Thakker, M. Caplin, G. Delle Fave, G.A. Kaltsas, E.P. Krenning, S.F. Moss, O. Nilsson, G. Rindi, R. Salazar, P. Ruszniewski and A. Sundin, Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 2008. 9(1): p. 61–72.PubMedCrossRef Modlin, I.M., K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, R.V. Thakker, M. Caplin, G. Delle Fave, G.A. Kaltsas, E.P. Krenning, S.F. Moss, O. Nilsson, G. Rindi, R. Salazar, P. Ruszniewski and A. Sundin, Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 2008. 9(1): p. 61–72.PubMedCrossRef
4.
Zurück zum Zitat Kloppel, G., A. Perren and P.U. Heitz, The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci, 2004. 1014: p. 13–27.PubMedCrossRef Kloppel, G., A. Perren and P.U. Heitz, The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci, 2004. 1014: p. 13–27.PubMedCrossRef
5.
Zurück zum Zitat Bosman, F.T., World Health Organization and International Agency for Research on Cancer, WHO classification of tumours of the digestive system. 4th ed. World Health Organization classification of tumours. 2010, Lyon: International Agency for Research on Cancer. 417 p. Bosman, F.T., World Health Organization and International Agency for Research on Cancer, WHO classification of tumours of the digestive system. 4th ed. World Health Organization classification of tumours. 2010, Lyon: International Agency for Research on Cancer. 417 p.
6.
Zurück zum Zitat Rindi, G., G. Kloppel, H. Alhman, M. Caplin, A. Couvelard, W.W. de Herder, B. Erikssson, A. Falchetti, M. Falconi, P. Komminoth, M. Korner, J.M. Lopes, A.M. McNicol, O. Nilsson, A. Perren, A. Scarpa, J.Y. Scoazec and B. Wiedenmann, TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2006. 449(4): p. 395–401.PubMedCentralPubMedCrossRef Rindi, G., G. Kloppel, H. Alhman, M. Caplin, A. Couvelard, W.W. de Herder, B. Erikssson, A. Falchetti, M. Falconi, P. Komminoth, M. Korner, J.M. Lopes, A.M. McNicol, O. Nilsson, A. Perren, A. Scarpa, J.Y. Scoazec and B. Wiedenmann, TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2006. 449(4): p. 395–401.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Boyar Cetinkaya, R., M. Vatn, L. Aabakken, D.S. Bergestuen and E. Thiis-Evensen, Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors. Scand J Gastroenterol, 2014. 49(6): p. 734–41. Boyar Cetinkaya, R., M. Vatn, L. Aabakken, D.S. Bergestuen and E. Thiis-Evensen, Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors. Scand J Gastroenterol, 2014. 49(6): p. 734–41.
8.
Zurück zum Zitat Cherenfant, J., S.J. Stocker, M.K. Gage, H. Du, T.A. Thurow, M. Odeleye, S.W. Schimpke, K.L. Kaul, C.R. Hall, I. Lamzabi, P. Gattuso, D.J. Winchester, R.W. Marsh, K.K. Roggin, D.J. Bentrem, M.S. Baker, R.A. Prinz and M.S. Talamonti, Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery, 2013. 154(4): p. 785–91; discussion 791–3.PubMedCrossRef Cherenfant, J., S.J. Stocker, M.K. Gage, H. Du, T.A. Thurow, M. Odeleye, S.W. Schimpke, K.L. Kaul, C.R. Hall, I. Lamzabi, P. Gattuso, D.J. Winchester, R.W. Marsh, K.K. Roggin, D.J. Bentrem, M.S. Baker, R.A. Prinz and M.S. Talamonti, Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery, 2013. 154(4): p. 785–91; discussion 791–3.PubMedCrossRef
9.
Zurück zum Zitat Bilimoria, K.Y., D.J. Bentrem, R.P. Merkow, J.S. Tomlinson, A.K. Stewart, C.Y. Ko and M.S. Talamonti, Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg, 2007. 205(4): p. 558–63.PubMedCrossRef Bilimoria, K.Y., D.J. Bentrem, R.P. Merkow, J.S. Tomlinson, A.K. Stewart, C.Y. Ko and M.S. Talamonti, Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg, 2007. 205(4): p. 558–63.PubMedCrossRef
10.
Zurück zum Zitat Ito, H., M. Abramson, K. Ito, E. Swanson, N. Cho, D.T. Ruan, R.S. Swanson and E.E. Whang, Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience. J Gastrointest Surg, 2010. 14(5): p. 891–8.PubMedCrossRef Ito, H., M. Abramson, K. Ito, E. Swanson, N. Cho, D.T. Ruan, R.S. Swanson and E.E. Whang, Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience. J Gastrointest Surg, 2010. 14(5): p. 891–8.PubMedCrossRef
11.
Zurück zum Zitat Han, X., X. Xu, D. Jin, D. Wang, Y. Ji and W. Lou, Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas, 2014. 43(4): p. 526–31.PubMedCentralPubMedCrossRef Han, X., X. Xu, D. Jin, D. Wang, Y. Ji and W. Lou, Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas, 2014. 43(4): p. 526–31.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Partelli, S., S. Gaujoux, L. Boninsegna, R. Cherif, S. Crippa, A. Couvelard, A. Scarpa, P. Ruszniewski, A. Sauvanet and M. Falconi, Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg, 2013. 148(10): p. 932–9.PubMedCrossRef Partelli, S., S. Gaujoux, L. Boninsegna, R. Cherif, S. Crippa, A. Couvelard, A. Scarpa, P. Ruszniewski, A. Sauvanet and M. Falconi, Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg, 2013. 148(10): p. 932–9.PubMedCrossRef
13.
Zurück zum Zitat Sarmiento, J.M., M.B. Farnell, F.G. Que and D.M. Nagorney, Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis. World J Surg, 2002. 26(10): p. 1267–71.PubMedCrossRef Sarmiento, J.M., M.B. Farnell, F.G. Que and D.M. Nagorney, Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis. World J Surg, 2002. 26(10): p. 1267–71.PubMedCrossRef
14.
Zurück zum Zitat Scarpa, A., W. Mantovani, P. Capelli, S. Beghelli, L. Boninsegna, R. Bettini, F. Panzuto, P. Pederzoli, G. delle Fave and M. Falconi, Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol, 2010. 23(6): p. 824–33.PubMedCrossRef Scarpa, A., W. Mantovani, P. Capelli, S. Beghelli, L. Boninsegna, R. Bettini, F. Panzuto, P. Pederzoli, G. delle Fave and M. Falconi, Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol, 2010. 23(6): p. 824–33.PubMedCrossRef
15.
Zurück zum Zitat Tomassetti, P., D. Campana, L. Piscitelli, R. Casadei, D. Santini, F. Nori, A.M. Morselli-Labate, R. Pezzilli and R. Corinaldesi, Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol, 2005. 16(11): p. 1806–10.PubMedCrossRef Tomassetti, P., D. Campana, L. Piscitelli, R. Casadei, D. Santini, F. Nori, A.M. Morselli-Labate, R. Pezzilli and R. Corinaldesi, Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol, 2005. 16(11): p. 1806–10.PubMedCrossRef
16.
Zurück zum Zitat Toste, P.A., B.E. Kadera, S.F. Tatishchev, D.W. Dawson, B.M. Clerkin, R. Muthusamy, R. Watson, J.S. Tomlinson, O.J. Hines, H.A. Reber and T.R. Donahue, Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival. J Gastrointest Surg, 2013. 17(12): p. 2105–13.PubMedCrossRef Toste, P.A., B.E. Kadera, S.F. Tatishchev, D.W. Dawson, B.M. Clerkin, R. Muthusamy, R. Watson, J.S. Tomlinson, O.J. Hines, H.A. Reber and T.R. Donahue, Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival. J Gastrointest Surg, 2013. 17(12): p. 2105–13.PubMedCrossRef
17.
Zurück zum Zitat Bettini, R., L. Boninsegna, W. Mantovani, P. Capelli, C. Bassi, P. Pederzoli, G.F. Delle Fave, F. Panzuto, A. Scarpa and M. Falconi, Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol, 2008. 19(5): p. 903–8.PubMedCrossRef Bettini, R., L. Boninsegna, W. Mantovani, P. Capelli, C. Bassi, P. Pederzoli, G.F. Delle Fave, F. Panzuto, A. Scarpa and M. Falconi, Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol, 2008. 19(5): p. 903–8.PubMedCrossRef
18.
Zurück zum Zitat Haynes, A.B., V. Deshpande, T. Ingkakul, P.A. Vagefi, J. Szymonifka, S.P. Thayer, C.R. Ferrone, J.A. Wargo, A.L. Warshaw and C. Fernandez-del Castillo, Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg, 2011. 146(5): p. 534–8.PubMedCentralPubMedCrossRef Haynes, A.B., V. Deshpande, T. Ingkakul, P.A. Vagefi, J. Szymonifka, S.P. Thayer, C.R. Ferrone, J.A. Wargo, A.L. Warshaw and C. Fernandez-del Castillo, Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg, 2011. 146(5): p. 534–8.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Rindi, G., M. Falconi, C. Klersy, L. Albarello, L. Boninsegna, M.W. Buchler, C. Capella, M. Caplin, A. Couvelard, C. Doglioni, G. Delle Fave, L. Fischer, G. Fusai, W.W. de Herder, H. Jann, P. Komminoth, R.R. de Krijger, S. La Rosa, T.V. Luong, U. Pape, A. Perren, P. Ruszniewski, A. Scarpa, A. Schmitt, E. Solcia and B. Wiedenmann, TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst, 2012. 104(10): p. 764–77.PubMedCrossRef Rindi, G., M. Falconi, C. Klersy, L. Albarello, L. Boninsegna, M.W. Buchler, C. Capella, M. Caplin, A. Couvelard, C. Doglioni, G. Delle Fave, L. Fischer, G. Fusai, W.W. de Herder, H. Jann, P. Komminoth, R.R. de Krijger, S. La Rosa, T.V. Luong, U. Pape, A. Perren, P. Ruszniewski, A. Scarpa, A. Schmitt, E. Solcia and B. Wiedenmann, TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst, 2012. 104(10): p. 764–77.PubMedCrossRef
20.
Zurück zum Zitat Kaplan, E.L. and P. Meier, Nonparametric Estimation from Incomplete Observations Journal of the American Statistical Association, 1958. 53(282): p. 457–481.CrossRef Kaplan, E.L. and P. Meier, Nonparametric Estimation from Incomplete Observations Journal of the American Statistical Association, 1958. 53(282): p. 457–481.CrossRef
21.
Zurück zum Zitat Hashim, Y.M., K.M. Trinkaus, D.C. Linehan, S.S. Strasberg, R.C. Fields, D. Cao and W.G. Hawkins, Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg, 2014. 259(2): p. 197–203.PubMedCentralPubMedCrossRef Hashim, Y.M., K.M. Trinkaus, D.C. Linehan, S.S. Strasberg, R.C. Fields, D. Cao and W.G. Hawkins, Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg, 2014. 259(2): p. 197–203.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Hasegawa, T., K. Yamao, S. Hijioka, V. Bhatia, N. Mizuno, K. Hara, H. Imaoka, Y. Niwa, M. Tajika, S. Kondo, T. Tanaka, Y. Shimizu, T. Kinoshita, T. Kohsaki, I. Nishimori, S. Iwasaki, T. Saibara, W. Hosoda and Y. Yatabe, Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy, 2014. 46(1): p. 32–8.PubMed Hasegawa, T., K. Yamao, S. Hijioka, V. Bhatia, N. Mizuno, K. Hara, H. Imaoka, Y. Niwa, M. Tajika, S. Kondo, T. Tanaka, Y. Shimizu, T. Kinoshita, T. Kohsaki, I. Nishimori, S. Iwasaki, T. Saibara, W. Hosoda and Y. Yatabe, Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy, 2014. 46(1): p. 32–8.PubMed
23.
Zurück zum Zitat Weynand, B., I. Borbath, V. Bernard, C. Sempoux, J.F. Gigot, C. Hubert, V. Lannoy, P.H. Deprez and A. Jouret-Mourin, Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathology, 2013. doi: 10.1111/cyt.12111 Weynand, B., I. Borbath, V. Bernard, C. Sempoux, J.F. Gigot, C. Hubert, V. Lannoy, P.H. Deprez and A. Jouret-Mourin, Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathology, 2013. doi: 10.1111/cyt.12111
24.
Zurück zum Zitat Katanuma, A., H. Maguchi, K. Yane, S. Hashigo, T. Kin, M. Kaneko, S. Kato, R. Kato, R. Harada, M. Osanai, K. Takahashi and M. Nojima, Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci, 2013. 58(7): p. 2093–9.PubMedCentralPubMedCrossRef Katanuma, A., H. Maguchi, K. Yane, S. Hashigo, T. Kin, M. Kaneko, S. Kato, R. Kato, R. Harada, M. Osanai, K. Takahashi and M. Nojima, Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci, 2013. 58(7): p. 2093–9.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Kishi, Y., K. Shimada, S. Nara, M. Esaki, N. Hiraoka and T. Kosuge, Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size. Ann Surg Oncol, 2014. p 28882–8 Kishi, Y., K. Shimada, S. Nara, M. Esaki, N. Hiraoka and T. Kosuge, Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size. Ann Surg Oncol, 2014. p 28882–8
26.
Zurück zum Zitat Manasanch, E.E., J.K. Smith, A. Bodnari, J. McKinney, C. Gray, T.P. McDade and J.F. Tseng, Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. J Oncol Pract, 2011. 7(2): p. 111–6.PubMedCentralPubMedCrossRef Manasanch, E.E., J.K. Smith, A. Bodnari, J. McKinney, C. Gray, T.P. McDade and J.F. Tseng, Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. J Oncol Pract, 2011. 7(2): p. 111–6.PubMedCentralPubMedCrossRef
Metadaten
Titel
Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection
verfasst von
Thomas Curran
Barbara A. Pockaj
Richard J. Gray
Thorvardur R. Halfdanarson
Nabil Wasif
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2624-z

Weitere Artikel der Ausgabe 1/2015

Journal of Gastrointestinal Surgery 1/2015 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.